Clinical Trial Update: A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers [Phase 4]

View source ↗

Summary

Phase 4 trial examining how rabeprazole-induced higher stomach pH affects APO-dabigatran exposure in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Venous Thromboembolism

Drugs mentioned

• APO-dabigatran (dabigatran)
• Rabeprazole (rabeprazole)

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation, Venous Thromboembolism | Phase 4 | Status: COMPLETED